Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1354545-57-5 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 • CH4O3S |
Formula Wt. | 635.18 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide methanesulfonate (1:1) |
Synonym | CEP 28122 Mesylate, CEP28122 Mesylate |
Solubility | 10 mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
Isoflavone found in legumes such as soy.
Alkaline phosphatase substrate used to quantify...
PI3K inhibitor.
Loop diuretic; NKCC symporter inhibitor, CFTR C...
Synthetic taxol synthesis intermediate; microtu...
D2 and 5-HT2A antagonist.
5-HT1A agonist, 5-HT2A antagonist.
Ansamycin; bacterial DNA-dependent RNA polymera...
ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...
Purine derivative; CDK inhibitor.
Tetracycline; FIASMA, histamine H1, 5-HT2, mACh...
PI3K and mTOR inhibitor.
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
PKC and PKG inhibitor.
Valosin-containing protein inhibitor.
Synthetic progestogen; PR agonist.
PI3K inhibitor.
p110α PI3K and mTOR inhibitor.
Walrycin response regulator inhibitor.
Imaging agent; Maillard reaction inhibitor.